Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FTU-Seek: Foundation Model-Guided Hard-Negative Learning for Sparse Functional Tissue Unit Segmentation. | Biomedicines | 2026 | 42792676 | PubTator, text mining | PubMed |
| Therapeutic intervention of PBK/TOPK: Bridging cellular signaling to drug discovery. | Pharmacol Res | 2026 | 42790834 | PubTator, text mining | PubMed |
| Gene Expression Biomarkers for Breast Ductal Carcinoma in Situ Recurrence Prediction. | Int J Cancer | 2026 | 42781949 | PubTator, text mining | PubMed |
| PDZ-binding kinase promotes ovarian cancer cell proliferation and invasion via CCNB1 regulation. | Transl Cancer Res | 2026 | 42724446 | PubTator, text mining | PubMed |
| Worenine attenuates pulmonary fibrosis potentially through modulation of PBK/SRC-associated TGF-β1/Smad and NF-κB signaling pathways. | Biomed Pharmacother | 2026 | 42700617 | PubTator, text mining | PubMed |
| A chemoresistance-associated proliferation gene signature identified by single-cell and machine learning analysis predicts prognosis in high-grade serous ovarian carcinoma. | Transl Oncol | 2026 | 42696959 | PubTator, text mining | PubMed |
| RTGNet: A Dual-Branch Network Integrating Recurrent Texture and Temporal Dynamics from sEMG for Lower-Limb Joint Angle Prediction. | Sensors (Basel) | 2026 | 42655451 | PubTator, text mining | PubMed |
| Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential. | Genes (Basel) | 2026 | 42650106 | PubTator, text mining | PubMed |
| TCGA-based identification and functional validation of PBK in intrahepatic cholangiocarcinoma progression with involvement of AKT signaling. | Transl Oncol | 2026 | 42594715 | PubTator, text mining | PubMed |
| Evidence for PDZ-Binding Kinase in Lung Disease With an Emphasis on PAH. | Pulm Circ | 2026 | 42516669 | PubTator, text mining | PubMed |
| Simulation and empirical evaluation of biologically-informed neural network performance. | Mach Learn Appl | 2026 | 42368786 | PubTator, text mining | PubMed |
Artificial Intelligence-Driven Construction of Predictive and Druggable Frameworks to an In Silico Bioengineering Evidence Support for Therapy of Esophageal Squamous Cell Carcinoma Patients: Insights from a Toll-like Receptor Signal with Th17 and T Helper Microenvironment. | Bioengineering (Basel) | 2026 | 42351867 | PubTator, text mining | PubMed |
| Elevated Plasma T-LAK cell-originated protein kinase Owned the Potential for Predicting Favorable Outcomes in Acute Ischemic Stroke Patients. | Cell Mol Neurobiol | 2026 | 42277369 | PubTator, text mining | PubMed |
| Targeting the TOPK-STAT3 pathway in keratinocytes and mast cells mediates the therapeutic attenuation of Atopic dermatitis. | Inflamm Res | 2026 | 42237026 | PubTator, text mining | PubMed |
| [Characterization of copy number variations in concomitant exotropia using single nucleotide polymorphism microarray]. | Zhonghua Yan Ke Za Zhi | 2026 | 42103667 | PubTator, text mining | PubMed |
| Advances in T-Lymphokine-activated Killer Cell-originated Protein Kinase Research in Cancer Over the Past Thirty Years. | J Cancer Prev | 2026 | 42079338 | PubTator, text mining | PubMed |
| PBK-Loaded secretory autophagosomes drive radiotherapy-induced systemic adipose depletion via MAPK/ERK-PRKA/PKA-LIPE/HSL signaling: a therapeutic target for esophageal cancer cachexia. | Autophagy | 2026 | 41988986 | PubTator, text mining | PubMed |
| Cell-Cell Interactome-Based Pathogenesis and Therapies for Osteosarcoma. | Cells | 2026 | 41892359 | PubTator, text mining | PubMed |
| TOPK Suppresses the CD8+ T Cell Antitumor Immunity via Modulation of IRF5 Expression. | Cancer Commun (Lond) | 2026 | 41868885 | PubTator, text mining | PubMed |
| A pruned and parameter-efficient Xception framework for skin cancer classification. | PLoS One | 2026 | 41805755 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers